XML 59 R40.htm IDEA: XBRL DOCUMENT
v3.22.4

Stock Option And Stock Award Plans (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract] |
Summary Of Stock Options Outstanding | summary of stock options outstanding at December 31, 2022, 2021 and 2020, and changes during those years, is presented below:
|  |  | Option Exercise Price/Share
| Number of Options |  | Range |  | Weighted Average
Outstanding at January 1, 2020 | 1,628,903 |  |  | $ | 15.65 |  |  | to |  | $ | 24.84 |  |  | $ | 19.13 |
Granted | 638,074 |  |  | 10.75 |  |  | to |  | 14.62 |  |  | 11.90 |
Modification for special cash dividend(a) | 701,535 |  |  | 10.75 |  |  | to |  | 14.62 |  |  | 11.90 |
Forfeited and expired(a) | (141,074) |  |  | 10.75 |  |  | to |  | 24.84 |  |  | 11.87 |
Outstanding at December 31, 2020(a) | 2,827,438 |  |  | 10.75 |  |  | to |  | 22.49 |  |  | 13.55 |
Granted | 388,822 |  |  | 16.37 |  |  | to |  | 16.37 |  |  | 16.37 |
Forfeited and expired | (22,611) |  |  | 14.47 |  |  | to |  | 19.64 |  |  | 18.14 |
Exercised | (67,705) |  |  | 10.75 |  |  | to |  | 17.29 |  |  | 13.51 |
Outstanding at December 31, 2021 | 3,125,944 |  |  | 10.75 |  |  | to |  | 22.49 |  |  | 13.82 |
Forfeited and expired | (17,203) |  |  | 14.47 |  |  | to |  | 19.64 |  |  | 15.33 |
Outstanding at December 31, 2022 | 3,108,741 |  |  | $ | 10.75 |  |  | to |  | $ | 22.49 |  |  | $ | 13.81 |
(a) The option exercise price per share reflects the reduction to the exercise prices of outstanding stock options impacted by the modification due to the anti-dilution provisions in the stock-based compensation plan.
Summary Of Additional Information On Stock Options Outstanding And Exercisable | The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2022:
|  |  |  |  |  | Options Outstanding at December 31, 2022 |  | Options Exercisable at December 31, 2022
|  |  |  |  |  |  |  | Weighted Average |  | Aggregate Intrinsic Value |  |  |  |  |  | Aggregate Intrinsic Value
Range of Exercise Prices |  | Shares |  | Remaining Contractual Life |  | Exercise Price |  |  | Shares |  | Weighted Average Exercise Price |
$ | 10.75 |  |  | to |  | $ | 16.37 |  |  | 2,939,509 |  |  | 3.4 years |  | $ | 13.47 |  |  | $ | — |  |  | 2,550,687 |  |  | $ | 13.03 |  |  | $ | — |
17.29 |  |  | to |  | 25.94 |  |  | 169,232 |  |  | 0.7 years |  | 19.74 |  |  | — |  |  | 169,232 |  |  | 19.74 |  |  | — |
Total |  | 3,108,741 |  |  | 3.3 years |  | $ | 13.82 |  |  | $ | — |  |  | 2,719,919 |  |  | $ | 13.45 |  |  | $ | — |
Summary Of Additional Information On Non-Vested Restricted Stock Outstanding | The following table summarizes additional information about unvested restricted stock outstanding at December 31, 2022, 2021 and 2020:
| Unvested Restricted Stock |  | Maximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria
| Number of Shares |  | Weighted Avg. Grant Date Fair Value/Share |  | Grant Date Fair Value (In thousands) |  | Number of Shares |  | Weighted Avg. Grant Date Fair Value/Share |  | Grant Date Fair Value (In thousands)
Outstanding at January 1, 2020 | 285,935 |  |  | $ | 18.27 |  |  | $ | 5,224 |  |  | 147,663 |  |  | $ | 21.25 |  |  | $ | 3,138 |
Granted | 155,138 |  |  | 14.55 |  |  | 2,257 |  |  | 34,275 |  |  | 15.25 |  |  | 523 |
Vested | (148,709) |  |  | 17.39 |  |  | (2,586) |  |  | (37,370) |  |  | 17.38 |  |  | (649) |
Forfeited | (57,385) |  |  | 17.00 |  |  | (976) |  |  | (32,066) |  |  | 17.36 |  |  | (557) |
Outstanding at December 31, 2020 | 234,979 |  |  | 16.68 |  |  | 3,919 |  |  | 112,502 |  |  | 21.82 |  |  | 2,455 |
Granted | 200,073 |  |  | 15.63 |  |  | 3,127 |  |  | 14,669 |  |  | 15.24 |  |  | 224 |
Vested | (87,636) |  |  | 15.78 |  |  | (1,383) |  |  | (73,930) |  |  | 17.17 |  |  | (1,269) |
Forfeited | (11,616) |  |  | 16.38 |  |  | (190) |  |  | (2,523) |  |  | 17.63 |  |  | (44) |
Outstanding at December 31, 2021 | 335,800 |  |  | 16.30 |  |  | 5,473 |  |  | 50,718 |  |  | 17.63 |  |  | 1,366 |
Granted | 301,969 |  |  | 11.88 |  |  | 3,587 |  |  | — |  |  | — |  |  | — |
Vested | (144,317) |  |  | 15.10 |  |  | (2,179) |  |  | — |  |  | — |  |  | — |
Forfeited | (18,474) |  |  | 14.94 |  |  | (276) |  |  | (50,718) |  |  | 17.63 |  |  | 1,366 |
Outstanding at December 31, 2022 | 474,978 |  |  | $ | 13.82 |  |  | $ | 6,564 |  |  | — |  |  | $ | — |  |  | $ | — |
Share-based Payment Arrangement, Stock Appreciation Right, Activity | A summary of SARs outstanding at December 31, 2022, 2021 and 2020, and changes during those years, is presented below:
|  |  | Exercise Price/Share
| Number of SARs |  | Range |  | Weighted Average
Outstanding at January 1, 2020 | — |  |  | $ | — |  |  | to |  | $ | — |  |  | $ | — |
Granted(a) | 387,252 |  |  | 10.75 |  |  | to |  | 19.64 |  |  | 11.60 |
Modification for special cash dividend | 71,402 |  |  | 10.75 |  |  | to |  | 19.64 |  |  | 11.60 |
Forfeited and expired | (82,214) |  |  | 10.75 |  |  | to |  | 19.64 |  |  | 11.39 |
Outstanding at December 31, 2020 | 376,440 |  |  | 10.75 |  |  | to |  | 19.64 |  |  | 11.64 |
Granted | 164,464 |  |  | 16.37 |  |  | to |  | 16.37 |  |  | 16.37 |
Forfeited and expired | (10,043) |  |  | 10.75 |  |  | to |  | 16.37 |  |  | 13.01 |
Exercised | (9,260) |  |  | 10.75 |  |  | to |  | 15.25 |  |  | 13.87 |
Outstanding at December 31, 2021 | 521,601 |  |  | 10.75 |  |  | to |  | 16.37 |  |  | 13.55 |
Forfeited and expired | (22,914) |  |  | 10.75 |  |  | to |  | 16.37 |  |  | 14.83 |
Outstanding at December 31, 2022 | 498,687 |  |  | $ | 10.75 |  |  | to |  | $ | 16.37 |  |  | $ | 13.49 |
(a) The SARs exercise price per share reflects the reduction to the exercise prices of outstanding SARs as a results of the modification to the awards pursuant to the nondiscretionary anti-dilution provisions in the related SAR s grant agreements.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration